An Integrated Model including the ROX Index to Predict the Success of High-Flow Nasal Cannula Use after Planned Extubation: A Retrospective Observational Cohort Study
High-flow nasal cannula (HFNC) therapy is commonly used to prevent reintubation after planned extubation. In clinical practice, there are no appropriate tools to evaluate whether HFNC therapy was successful or failed after planned extubation. In this retrospective observational study, we investigate...
Main Authors: | Young Seok Lee, Sung Won Chang, Jae Kyeom Sim, Sua Kim, Je Hyeong Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/16/3513 |
Similar Items
-
Cardiac Dysfunction Is Not Associated with Increased Reintubation Rate in Patients Treated with Post-extubation High-Flow Nasal Cannula
by: Jae Kyeom Sim, et al.
Published: (2022-10-01) -
High-flow nasal oxygen cannula vs. noninvasive mechanical ventilation to prevent reintubation in sepsis: a randomized controlled trial
by: Surat Tongyoo, et al.
Published: (2021-09-01) -
The ROX index: “Propelled” by high-flow nasal cannula therapy during the COVID-19 pandemic into greater applicability in respiratory support
by: Lucélia Luna Melo-Diaz, et al.
Published: (2022-11-01) -
The value of ROX index in predicting the outcome of high flow nasal cannula: a systematic review and meta-analysis
by: Zhen Junhai, et al.
Published: (2022-02-01) -
ROX index versus HACOR scale in predicting success and failure of high-flow nasal cannula in the emergency department for patients with acute hypoxemic respiratory failure: a prospective observational study
by: Nattakarn Praphruetkit, et al.
Published: (2023-01-01)